It functions as an oncogene, enhancing proliferation, invasion, and chemoresistance in breast and gastric cancers, partly through its interactions with key signaling pathways such as PI3K/AKT (Hu et al., 2022; Islam et al., 2024). The gene discussed is AKT1; the disease is gastric cancer.